Use of Live Microbial Consortia as Companion Therapy to Enhance the Efficacy of Immune Checkpoint Inhbitors in Oncology
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Gusto Global, LLC
Award Date
Award Amount
250,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Mark Spizer
Fiscal Year
2021
Region
Greater Charlotte
Project Description:
Gusto Global is developing a novel live bacterial consortia that address unmet medical needs. The company has been awarded a SRL loan to test a novel live bacterial therapy (GUT-115) designed to overcome immune dormancy (non-response) found with up to 60% of melanoma patients undergoing anti-PD-1 immunotherapy.